Latisse costs $90 to $120 for a month’s supply and is not covered by insurance. It is identical to Allergan’s glaucoma drug Lumigan, an eyedrop that spurs eyelash growth as a side effect. Athena’s product, by contrast, costs $150 for a six-month supply.
The issue is likely to remain a top priority for Allergan. The company is currently testing the same compound as a therapy for baldness, a move that, if successful, could open up a $1 billion market, the company said.
Roll Call has launched a new feature, Hill Navigator, to advise congressional staffers and would-be staffers on how to manage workplace issues on Capitol Hill. Please send us your questions anything from office etiquette, to handling awkward moments, to what happens when the work life gets too personal. Submissions will be treated anonymously.